Sep 01, 2023
Oversedation and Failure to Resuscitate in Dentistry
This case discussion covers risk management issues involving sedation and provides strategies to help practices keep patients safe.
Search
The Doctors Company Announces $8.5 Million Member Dividend
We are proud to announce The Doctors Company has approved a 2023 premium dividend of approximately $8.5 million, bringing the total of declared dividends to date to more than $455 million.
Apr 29, 2020
The Faintest Ink: Documentation to Defend Quality Patient Care
Complete and timely documentation of the medical record not only enhances patient care, but it also serves to strengthen your credibility if you are called upon to defend that care.
April 13, 2022, Medical Economics
Why Patients Sue Their Doctor
Robert E. White, Jr., Chief Operating Officer of The Doctors Company and TDC Group, details why most lawsuits occur due to patient frustration with not getting answers to their questions regarding an unexpected outcome.
October 01, 2024, Cardiology Magazine
Misdiagnosis: Lessons Learned From a Cardiology Malpractice Case
This article, co-authored by Debra Davidson, MJ, CPHRM, CPPS, Senior Patient Safety Risk Manager for The Doctors Company, discusses how delayed diagnosis of myocardial infarction (MI) is a top malpractice allegation in cardiology.
February 17, 2025, FDA Storm Proof: Plan for Every Possible Path
Disaster Preparedness for Your Dental Practice
Julie M. Brightwell, BSN, JD, RN, CPHRM, Director, Patient Safety, The Doctors Company, part of TDC Group, provides disaster preparedness recommendations for dental practices.
June 01, 2023, Chicago Medicine
Childhood Obesity: Communication Strategies for Healthcare Practitioners
This article by Patti L. Ellis, RN, CPHRM, Patient Safety Risk Manager II, The Doctors Company, discusses important lessons learned and practice improvement strategies surrounding childhood obesity for pediatric healthcare practitioners.
June 01, 2024, Healthcare Risk Management
Falls Remain a Leading Safety Problem, Still Need Attention
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, provides insight on how practices should respond to and prevent patient falls.
August 04, 2023, MDLinx
Iowa Neurosurgeon Beats $27 Million Malpractice Suit
David L. Feldman, MD, MBA, FACS, Chief Medical Officer for The Doctors Company and TDC Group, discusses the correlation between patient safety and malpractice risk.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.